Mesothelioma
Mesothelioma is a rare and aggressive cancer that develops in the lining of the lungs, abdomen, or heart, often caused by exposure to asbestos. Symptoms may include chest pain, persistent cough, and difficulty breathing.
Advanced Mesothelioma: Pembrolizumab and Dendritic Cell Vaccine
We are studying a combination of pembrolizumab and a personalized vaccine for patients with advanced mesothelioma who have not responded to earlier treatments. The goal is to see if this approach can improve outcomes for these patients.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Istituto Romagnolo Per Lo Studio Dei Tumori Dino Amadori IRST S.r.l.
Experimental and Clinical Oncology of Immunotherapy and Rare Cancers Unit
Meldola, Italy
Sponsor: Istituto Romagnolo Per Lo Studio Dei Tumori Dino Amadori IRST S.r.l.
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.